Phillip Pang - 02 Jan 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Reporting relationship: EVP & Chief Medical Officer
Issuer ticker: VIR
Reported as of: 02 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jan 2024, 14:47:59 UTC
Prior SEC filing: 08 Jun 2023
Next SEC filing: 16 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Sung Lee, Attorney-in-Fact

Key filing fact

Phillip Pang filed Form 4 for Vir Biotechnology, Inc. (VIR) on 03 Jan 2024.

Key facts

This page summarizes Phillip Pang's Form 4 filing for Vir Biotechnology, Inc. (VIR).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Jan 2024, 14:47.

Change

Previous filing in this sequence was filed on 08 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIR transaction

Common Stock

Options Exercise

Transaction value: $16,102
Shares: +18,833
Change %: +10%
Price: $0.8550
Shares after: 206,833
Date: 02 Jan 2024
Ownership: Direct

VIR transaction

Common Stock

Options Exercise

Transaction value: $21,382
Shares: +13,576
Change %: +6.6%
Price: $1.58
Shares after: 220,409
Date: 02 Jan 2024
Ownership: Direct

VIR transaction

Common Stock

Options Exercise

Transaction value: $72,814
Shares: +47,591
Change %: +22%
Price: $1.53
Shares after: 268,000
Date: 02 Jan 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $16,102
Shares: -18,833
Change %: -100%
Price: $0.8550
Shares after: 0
Date: 02 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,833
Exercise price: $0.8550
Footnotes: F1

VIR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $21,382
Shares: -13,576
Change %: -100%
Price: $1.58
Shares after: 0
Date: 02 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,576
Exercise price: $1.58
Footnotes: F2

VIR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $72,814
Shares: -47,591
Change %: -100%
Price: $1.53
Shares after: 0
Date: 02 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 47,591
Exercise price: $1.53
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

1/4 of the shares subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.

Footnote F2

1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vested in 36 equal monthly installments thereafter.

Footnote F3

1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vested in 36 equal monthly installments thereafter.